Evaluation of the prototype device for glucose monitoring by oral glucose tolerance test - Evaluation of the prototype device for glucose monitoring by oral glucose tolerance test

APO PLUS STATION CO., LTD.0 个研究点目标入组 50 人开始时间: 2024年1月30日最近更新: 2024年4月23日

试验速览

暂无简介。

•1)Subjects who are on treatment for a serious illness. 2)Subjects who have been diagnosed with diabetes and under treatment or medication. 3)Subjects who are may develop allergies in connection with the oral glucose tolerance test. 4)Subjects who regularly use licensed drugs or quasi-drugs that may affect the study. 5)Subjects who are currently on treatment at a medical institution for a disease that may affect the study. 6)Subjects who are participating in a clinical trial or have participated in another clinical trial within 1 month before the date of consent for this study. 7)Subjects who are pregnant and those who are breastfeeding. 8)Subjects who plan to participate in another clinical trial during the study period. 9)Subjects who have difficulty in wearing the prototype device. 10)Subjects who have difficulty in wearing continuous glucose monitoring. 11)Subjects who have difficulty in blood drawing from their fingertips by themselves. 12)Subjects who judged as unsuitable for this study by the principal investigator for any reasons.

发起方